Alpha Cognition Inc. Common Stock

ACOGNASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
5.82 USD
↘ 0.09 (1.52%)AT CLOSE (11:59 AM EDT)
5.79
↘ 0.04 (0.60%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
5.79
↘ 0.04 (0.60%)
🔴Market: CLOSED
Open?$5.90
High?$6.03
Low?$5.55
Prev. Close?$5.91
Volume?45.5K
Avg. Volume?35.1K
VWAP?$5.84
Rel. Volume?1.30x
Bid / Ask
Bid?$4.30 × 100
Ask?$6.88 × 100
Spread?$2.58
Midpoint?$5.59
Valuation & Ratios
Market Cap?128.7M
Shares Out?N/A
Float?19.1M
Float %?87.8%
P/E Ratio?N/A
P/B Ratio?2.24
EPS?-$1.15
Dividend?0.00%
Ex-Dividend?N/A

Alpha Cognition Inc. Common Stock (ACOG) trades at $5.81 per share. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. ACOG is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Themes
Biotech - Drug Development›Neuroscience & CNSLongevity & Aging›Age-Related Therapeutics
Employees
71
Market Cap
132.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.alphacognition.com
Listed
2021-06-09
Address
1452 HUGHES RD., STE. 200
GRAPEVINE, TX 76051
Phone: (858) 344-4375
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
95
Momentum?
35
Short Sent.?
73
Piotroski F-Score?0/9Weak
Altman Z-Score?4.41Safe
Confidence?40%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?0.99%Low
Short Interest?188.8K
Days to Cover?5.7
Free Float19.1M
Avg Daily Volume33.3K
Settlement Date2026-05-15
Financial Health
Current Ratio?12.63Strong
Quick Ratio?11.51Strong
Cash Ratio?10.00Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
69
2.24CHEAP▾
P/S?
Peers
100
S&P
5
11.89HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.8CHEAP▾
EV/Sales?
Peers
100
S&P
21
6.88HIGH▾
Returns & Efficiency
ROE?
S&P
3
-43.8%WEAK▾
ROA?
S&P
3
-36.3%WEAK▾
Cash Flow & Enterprise
FCF?$-30365620
Enterprise Value?$74.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist